GI & Endoscopy

Here are the five most popular gastroenterology and endoscopy stories for the week of July 12 to July 18, 2018.

Anticipating strong quarterly earnings for Exact Sciences, TheStreet believes the Cologuard-maker is in line for growth.

A study published in BMJ showed sigmoidoscopies had little effect on incidence or mortality rates in women aged 50 to 64, Medical News Bulletin reported.

Allergy and immunology, rheumatology, specialized surgery and critical care residents were the top four highest paid this year, beating gastroenterology residents in the No. 5 slot, according to the Medscape 2018 Residents Salary & Debt Report.

Nadege Gunn, MD, is a gastroenterologist at Austin (Texas) Gastroenterology.

Here are three updates on GI companies from the past week:

Lumendi's DiLumen EIP earned CE certification.

Takeda has a new "core country" in its sights: China, Bloomberg reports.

Boston Scientific's endoscopy, urology and pelvic health divisions are propelling the company's growth, Seeking Alpha reports.

Gastroenterology purchasing organization Gastrologix partnered with Stratis Medical to distribute Stratis products.